Pateclizumab (Anti-TNFSF1 / TNFb)

Synonyms: anti-lymphotoxin- alpha; MLTA3698A

Pateclizumab (Anti-TNFSF1 / TNFb) is a humanized monoclonal antibody that blocks and depletes anti-lymphotoxin α (LTα). It has a great potential for the treatment of rheumatoid arthritis (RA). MW : 145.5 KD.

Pateclizumab (Anti-TNFSF1 / TNFb)

Purity & Quality Control

≥99

Biological Activity

Description Pateclizumab (Anti-TNFSF1 / TNFb) is a humanized monoclonal antibody that blocks and depletes anti-lymphotoxin α (LTα). It has a great potential for the treatment of rheumatoid arthritis (RA). MW : 145.5 KD.

Product Details

CAS No. 1202526-59-7
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Pateclizumab (Anti-TNFSF1 / TNFb) | Pateclizumab (Anti-TNFSF1 / TNFb) supplier | purchase Pateclizumab (Anti-TNFSF1 / TNFb) | Pateclizumab (Anti-TNFSF1 / TNFb) cost | Pateclizumab (Anti-TNFSF1 / TNFb) manufacturer | order Pateclizumab (Anti-TNFSF1 / TNFb) | Pateclizumab (Anti-TNFSF1 / TNFb) distributor